Alvaro Moreno‐Aspitia

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low–Expressing Advanced Breast Cancer: Results From a Phase Ib Study

Shanu Modi, Haeseong Park, Rashmi K. Murthy et al. · Journal of Clinical Oncology · 2020 · 817 citations · Full text

Medicine, Oncology, Pharmacology +17

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

Edith A. Perez, Vera J. Suman, Nancy E. Davidson et al. · Journal of Clinical Oncology · 2011 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)

Hope S. Rugo, William T. Barry, Alvaro Moreno‐Aspitia et al. · Journal of Clinical Oncology · 2015 · 231 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

Jia Yu, Bo Qin, Ann M. Moyer et al. · Journal of Clinical Investigation · 2018 · 210 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial

Amir Sonnenblick, Dominique Agbor‐Tarh, Ian Bradbury et al. · Journal of Clinical Oncology · 2017 · 167 citations

Medicine, Oncology, Pharmacotherapy +17